CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHOD OF PREPARATION THEREOF

The present invention relates to a group of novel compounds, methods for their manufacture and the use of these compounds as research tools and as pharmaceuticals. The novel compounds are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of novel cannabidiol compounds..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 25. Okt. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

SILCOCK ALAN JAMES [VerfasserIn]
MILLET ANTOINE [VerfasserIn]
TSE KAREN KA-YEN [VerfasserIn]
HINCHLIFFE PAUL STUART [VerfasserIn]
SHARPE ANDREW [VerfasserIn]
SIMPSON IAIN DAVID [VerfasserIn]
PEACH JOANNE [VerfasserIn]
LEVANTO STEFANO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61P: Specific therapeutic activity of chemical compounds (...)
C07C: Acyclic or carbocyclic compounds (macromolecular co (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-10-25, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01

Patentnummer:

EP4262980

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018329799